Literature DB >> 11468688

Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.

O Bénichou1, E Cleiren, J Gram, J Bollerslev, M C de Vernejoul, W Van Hul.   

Abstract

The osteopetroses are a heterogeneous group of conditions characterized by a bone-density increase due to impaired bone resorption. As well as the two or more autosomal recessive types, two autosomal dominant forms of osteopetrosis, differentiated by clinical and radiological signs, are described. Autosomal dominant osteopetrosis (ADO) type II, also known as "Albers-Schönberg disease," is characterized by sclerosis, predominantly involving the spine (vertebral end-plate thickening, or Rugger-Jersey spine), the pelvis ("bone-within-bone" structures), and the skull base. An increased fracture rate can be observed in these patients. By linkage analysis, the presence, on chromosome 1p21, of a gene causing ADO type II was previously suggested. However, analysis of further families with ADO type II indicated genetic heterogeneity within ADO type II, with the chromosome 1p21 locus being only a minor locus. We now perform a genomewide linkage scan of a French extended family with ADO type II, which allows us to localize an ADO type II gene on chromosome 16p13.3. Analysis of microsatellite markers in five further families with ADO type II could not exclude this chromosomal region. A summed maximum LOD score of 12.70 was generated with marker D16S3027, at a recombination fraction (straight theta) of 0. On the basis of the key recombinants in the families, a candidate region of 8.4 cM could be delineated, flanked by marker D16S521, on distal side, and marker D16S423, on the proximal side. Surprisingly, one of the families analyzed is the Danish family previously suggested to have linkage to chromosome 1p21. Linkage to chromosome 16p13.3 clearly cannot be excluded in this family, since a maximum LOD score of 4.21 at theta=0 is generated with marker D16S3027. Because at present no other family with ADO type II has proved to have linkage to chromosome 1p21, we consider the most likely localization of the disease-causing gene in this family to be to chromosome 16p13.3. This thus reopens the possibility that ADO type II is genetically homogeneous because of a single gene on chromosome 16p13.3.

Entities:  

Mesh:

Year:  2001        PMID: 11468688      PMCID: PMC1235505          DOI: 10.1086/323132

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis.

Authors:  O D Bénichou; B Bénichou; H Copin; M C De Vernejoul; W Van Hul
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

Review 2.  Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects.

Authors:  J Bollerslev
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

3.  Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.

Authors:  O D Bénichou; J D Laredo; M C de Vernejoul
Journal:  Bone       Date:  2000-01       Impact factor: 4.398

4.  Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

Authors:  U Kornak; D Kasper; M R Bösl; E Kaiser; M Schweizer; A Schulz; W Friedrich; G Delling; T J Jentsch
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

5.  Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis.

Authors:  J Bollerslev; P E Andersen
Journal:  Bone       Date:  1988       Impact factor: 4.398

6.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

7.  Heterogeneity of autosomal dominant osteopetrosis.

Authors:  P E Andersen; J Bollerslev
Journal:  Radiology       Date:  1987-07       Impact factor: 11.105

8.  Osteopetrosis. A genetic and epidemiological study.

Authors:  J Bollerslev
Journal:  Clin Genet       Date:  1987-02       Impact factor: 4.438

9.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

Authors:  W S Sly; D Hewett-Emmett; M P Whyte; Y S Yu; R E Tashian
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.

Authors:  A Frattini; P J Orchard; C Sobacchi; S Giliani; M Abinun; J P Mattsson; D J Keeling; A K Andersson; P Wallbrandt; L Zecca; L D Notarangelo; P Vezzoni; A Villa
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

View more
  16 in total

1.  Paget's disease of bone or osteopetrosis?

Authors:  Alexander Rozin; Rachel Bar-Shalom; Sofia Ish-Shalom
Journal:  Clin Rheumatol       Date:  2005-10-19       Impact factor: 2.980

2.  Osteomyelitis of the mandible in a patient with osteopetrosis. Case report and review of the literature.

Authors:  Carlos Moreno García; María Asunción Pons García; Raúl González García; Florencio Monje Gil
Journal:  J Maxillofac Oral Surg       Date:  2011-04-20

3.  Fractures in patients with osteopetrosis, insights from a single institution.

Authors:  Anuj Chawla; Ernest Beng Kee Kwek
Journal:  Int Orthop       Date:  2018-10-04       Impact factor: 3.075

Review 4.  Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Authors:  T Segovia-Silvestre; A V Neutzsky-Wulff; M G Sorensen; C Christiansen; J Bollerslev; M A Karsdal; K Henriksen
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

5.  Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II).

Authors:  Zhen-Lin Zhang; Jin-Wei He; Hao Zhang; Wei-Wei Hu; Wen-Zhen Fu; Jie-Mei Gu; Jin-Bo Yu; Gao Gao; Yun-Qiu Hu; Miao Li; Yu-Juan Liu
Journal:  J Bone Miner Metab       Date:  2009-03-14       Impact factor: 2.626

6.  [Case report: total hip replacement for osteopetrosis ossificans. Femoral neck nonunion].

Authors:  O Schoierer; R Hoffmann
Journal:  Unfallchirurg       Date:  2007-09       Impact factor: 1.000

Review 7.  Case reports: treatment of subtrochanteric and ipsilateral femoral neck fractures in an adult with osteopetrosis.

Authors:  Patrick Birmingham; Kathleen A McHale
Journal:  Clin Orthop Relat Res       Date:  2008-04-23       Impact factor: 4.176

8.  A novel inhibitory mechanism of nitrogen-containing bisphosphonate on the activity of Cl- extrusion in osteoclasts.

Authors:  Kimiko Ohgi; Hiroshi Kajiya; Fujio Okamoto; Yoshiyuki Nagaoka; Tokuya Onitsuka; Atsushi Nagai; Ryuji Sakagami; Koji Okabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-06       Impact factor: 3.000

9.  Characteristics of ClC7 Cl- channels and their inhibition in mutant (G215R) associated with autosomal dominant osteopetrosis type II in native osteoclasts and hClcn7 gene-expressing cells.

Authors:  Hiroshi Kajiya; Fujio Okamoto; Kimiko Ohgi; Akihiro Nakao; Hidefumi Fukushima; Koji Okabe
Journal:  Pflugers Arch       Date:  2009-06-19       Impact factor: 3.657

Review 10.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.